Guardant Health Inc. GH
Super Investor & Insider
1
Fondi che lo detengono
#1215
Rank consenso
1.4%
% dei portafogli
$3.2M
Valore detenuto
| Fondo | % portaf. | Attività | Azioni | Valore |
|---|---|---|---|---|
| Polen Capital Management · Polen Capital Management | 0.02% | Add 76.56% | 34,725 | $3.2M |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Guardant Health Inc. is a precision oncology company that develops and provides blood and tissue-based tests, along with vast data sets and advanced analytics, to support cancer treatment, monitoring, and early detection. Its core offerings include the Guardant360 family of liquid biopsy tests, such as Guardant360 CDx …
SectorHealthcare
ExchangeNASDAQ
IndustryDiagnostics & Research
CountryUnited States
Employees2,490
TickerGH
Statistics
Market Cap$16.89B
Revenue (TTM)$982.0M
Net Income-$416.3M
Net Margin-42.4%
EPS$-3.32
P/E-39.45
P/S16.07
P/B-94.96
EV/EBITDA-43.94
ROE419.2%
Dividend Yield—
Price$128.45
Data: Twelve Data · Revenue = mcap / P/S